Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-29

FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propylthiouracil (propylthiouracil)

Snippet

SUPPL AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)